Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study

BACKGROUND: Oral prednisolone is the mainstay treatment for bullous pemphigoid, an autoimmune blistering skin disorder affecting older people. Treatment with moderate-to-high doses is often initiated in secondary care, but then continued in primary care. AIM: To describe long-term oral prednisolone...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Monica SM, Harman, Karen E, Thomas, Kim S, Chalmers, Joanne R, Vinogradova, Yana, Langan, Sinead M, Hippisley-Cox, Julia, Gran, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510692/
https://www.ncbi.nlm.nih.gov/pubmed/34607796
http://dx.doi.org/10.3399/BJGP.2020.0870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510692/
https://www.ncbi.nlm.nih.gov/pubmed/34607796
http://dx.doi.org/10.3399/BJGP.2020.0870

Ejemplares similares